Displaying growth conditions 1076 - 1100 of 1187 in total
ECMDB IDNameConcentrationStrain
Media
Growth Status
Growth System
TemperatureCitation
ECMDB00187L-Serine343± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00189Inosine triphosphate207± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB04148D-Ribulose 5-phosphate78± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00191L-Aspartic acid337± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00195Inosine31± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB04166Uridine diphosphate glucuronic acid83± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB04171UDP-Glucose1910± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00214Ornithine120± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00217NADP110± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00223Oxalacetic acid30± 1 uMBW25113
M9 Minimal Media, 4 g/L Glucose
Mid-Log Phase
Bioreactor, pH controlled, O2 controlled, dilution rate: 0.2/h
37 oCPMID: 15158257
ECMDB00239Pyridoxine1± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB20123beta-D-Fructose 1,6-bisphosphate1010± 100 uMBW25113
M9 Minimal Media, 4 g/L Glucose
Mid-Log Phase
Bioreactor, pH controlled, O2 controlled, dilution rate: 0.2/h
37 oCPMID: 15158257
ECMDB00263Phosphoenolpyruvic acid70± 6 uMBW25113
M9 Minimal Media, 4 g/L Glucose
Mid-Log Phase
Bioreactor, pH controlled, O2 controlled, dilution rate: 0.2/h
37 oCPMID: 15158257
ECMDB20274Ethylenediamine70± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00285Uridine triphosphate663± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00288Uridine 5'-monophosphate129± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21396Urocanic acid69± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21397Citraconic acid20± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21399Azelaic acid20± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21400Pterin24± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00290Uridine diphosphate-N-acetylglucosamine542± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21401N-Acetyl-L-aspartic acid141± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB21402Isobutyryl-CoA8± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB00295Uridine 5'-diphosphate386± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
ECMDB214032-Aminoisobutyric acid11± 0 uMBW25113
48 mM Na2HPO4, 22 mM KH2PO4, 10 mM NaCl, 45 mM (NH4)2SO4, supplemented with 1 mM MgSO4, 1 mg/l thiamine·HCl, 5.6 mg/l CaCl2, 8 mg/l FeCl3, 1 mg/l MnCl2·4H2O, 1.7 mg/l ZnCl2, 0.43 mg/l CuCl2·2H2O, 0.6 mg/l CoCl2·2H2O and 0.6 mg/l Na2MoO4·2H2O. 4 g/L Gluco
Stationary Phase, glucose limited
Bioreactor, pH controlled, O2 and CO2 controlled, dilution rate: 0.2/h
37 oCPMID: 17379776
Displaying growth conditions 1076 - 1100 of 1187 in total